EUCR
Eucrates Biomedical Acquisition
EUCR | NASDAQ
Chart Builder DCF Calculator
$10.04
$0.00 (0.00%)
At close: Apr 26, 2023, 03:14 PM ET

Eucrates Biomedical Acquisition Company Profile

Company profile explained

Company Profile

Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe. Established in 2020, this entity has its headquarters situated in New York, New York.

Key Executives

Name Position
Parag Phoolchand Saxena Chief Executive Officer & Director
Evangelos Vergetis Pres, Chief Operating Officer & Director
Gonzalo Cordova Chief Financial Officer
Shrikant Sathe Senior Vice President

Latest SEC Filings

No SEC filings available
View All SEC Filings ➞
Eucrates Biomedical Acquisition
EUCR
Country United States
IPO Date Dec 28, 2020
Industry Shell Companies
Sector Financial Services
Employees n/a
CEO Parag Phoolchand Saxena MBA, MS

Contact Details

250 West 55th Street New York City, New York 10019 United States
n/a

Stock Details

Ticker Symbol EUCR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001822929
CUSIP Number G3141W106
ISIN Number VGG3141W1068
SIC Code 6770

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.